心臟瓣膜病  (65p)課件_第1頁(yè)
心臟瓣膜病  (65p)課件_第2頁(yè)
心臟瓣膜病  (65p)課件_第3頁(yè)
心臟瓣膜病  (65p)課件_第4頁(yè)
心臟瓣膜病  (65p)課件_第5頁(yè)
已閱讀5頁(yè),還剩60頁(yè)未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

Valvular Heart Disease,Reading,Klabunde, Cardiovascular Physiology Concepts CD ROM material on Valve Disease,Overview of Valves,Major Factors That Affect Flow Across Any Valvular Lesion,The valve area The square root of the hydrostatic pressure gradient across the valve The time duration of transvalvular flow (applies to both systole and diastole),Valvular Heart Disease,Increasing any of the major factors that affect flow across the valve increases transvalvular flow. Conversely, decreasing any of these major factors decreases transvalvular flow.,Goals in Management of Various Valvular Lesions,Regurgitant Lesions Reduce or minimize regurgitant flow across the mitral or aortic valve. Stenotic Lesions Maximize and enhance stenotic flow across the mitral or aortic valve,Goals in Management of Various Valvular Lesions,The valve area in regurgitant lesions can respond to changes in loading conditions (preload, afterload) The valve area with stenotic lesions is generally fixed,Adult Valvular Heart Disease,Aortic Stenosis Aortic Regurgitaiton Mitral Stenosis Mitral Regurgitation Hypertrophic Obstructive Cardiomyopathy,Aortic Stenosis,Aortic Stenosis,Normal AVA = 2.6 3.5 cm2 Idiopathic Calcific Degeneration Congenital Bicuspid Endocarditis Other Pagets Disease Systemic Lupus Erythematosus,Aortic Stenosis,Aortic Stenosis: Senile,Natural History of AS,May be a long asymptomatic period Symptomatic Usually have severe AS with AVA of 0.9 cm2 or less Presenting symptoms: Angina Syncope CHF,Natural History of AS,Symptomatic patients without surgery show the following average life spans: Angina = 5 years Syncope = 3 years CHF = 2 years AS is considered an independent risk factor for perioperative morbidity,Survival of Patients with Valvular Heart Disease Treated Medically,Pathophysiology of Aortic Stenosis,Aortic Stenosis,Obstruction to LV Ejection,Chronic LV Pressure Overload,LV Hypertrophy,Pressure Gradient Created Across the Valve,Myocardial Function,Develop left ventricular hypertrophy as an adaptation LVH reduces wall stress T =(Pr)/h LVH causes increased diastolic stiffness,Ischemia in AS,Hypertrophied LV muscle mass Increased systolic pressure Prolongation of ejection Shortened diastolic time Relative decrease in myocardial capillary density High incidence of concomitant coronary artery disease,Aortic Stenosis,Measuring the Valve Gradient in AS,Mean gradient Peak-to-peak gradient Peak instantaneous gradient,Degree of Stenosis,Critical AS Peak systolic pressure gradient 50 mmHg AVA 0.9 cm2 Moderate AS 1.0 1.4 cm2 Mild AS 1.5 2.0 cm2,Aortic Stenosis,AORTIC STENOSIS: HEMODYNAMIC GOALS,Aortic Regurgitation,Aortic Regurgitation (Insufficiency),Rheumatic heart disease Endocarditis Aortic root dissection Trauma Connective tissue disorders Dexfenfluramine (appetite suppressant),Aortic Regurgitation,Natural History,Long asymptomatic period during which the LV undergoes progressive eccentric hypertrophy CHF Angina,Aortic Regurgitation,Pathophysiology of Aortic Regurgitation,Backward flow of blood from aorta into LV (Diastolic),Increased LV volume and pressure,Increased SV (Frank-Starling Mechanism),Peak systolic pressure increased because of increased SV ejected into aorta,Increased diastolic wall-tension produces eccentric hypertrophy,Rapid fall of aortic pressure during diastole,Increased pulse pressure,Increased LA pressure,Increased pulmonary venous pressure,Pulmonary edema,Pathophysiology,LV overloading Increased diastolic wall-tension produces eccentric hypertrophy (increase both in chamber size and wall thickness) Reduced diastolic compliance (Acute AI) Very high diastolic compliance (Chronic AI),Eccentric Hypertrophy,Pathophysiology,Baseline myocardial oxygen demand higher than normal because of increased LV mass Reduced coronary perfusion pressure Lower diastolic pressure Increased LVEDP,Pathophysiology,Myocardial contractility is usually preserved until late in course of the disease Late in disease there is progression to irreversible contractile impairment,Aortic Regurgitation,AORTIC REGURGITATION: HEMODYNAMIC GOALS,Mitral Stenosis,Normal MVA = 4 6 cm2,Mitral Stenosis,Causes: Rheumatic Women 4x Men Congenital Rheumatoid arthritis Systemic Lupus Erythematosus Carcinoid Syndrome Asymptomatic for approximately 20 years Presenting symptoms: CHF (50%) Atrial fibrillation,Mitral Stenosis,Pathophysiology of Mitral Stenosis,Obstruction to LA emptying,Increased LA pressure,Increased LA size,Atrial fibrillation,Increased pulmonary artery pressure,Decreased LV filling,RV overload,Increased pulmonary venous pressure,Pulmonary edema,Mitral Stenosis,Pathophysiology,Chronic obstruction to left atrial emptying during diastole LV chronically volume-underloaded Chronic volume and pressure over-loading of the left atrium and structures behind it,Pressure Gradient across the Mitral Valve,Pressure Gradient CO = Cardiac Output DFP = Diastolic Filling Period,Pathophysiology: LV,LV function is usually normal Decreased LVEF in about 1/3 of MS patients: Rheumatic carditis Chronic volume underloading Concomitant CAD Septal hypertrophy in patients with pulmonary hypertension (PHT),Pathophysiology: RV,RV function is normal in absence of pulmonary hypertension (PHT) Severe pulmonary hypertension will result in RV failure and secondary abnormalities of LV function,Mitral Stenosis,MITRAL STENOSIS: HEMODYNAMIC GOALS,Mitral Regurgitation (Insufficiency),Mitral Regurgitation (Insufficiency),Valve leaflets Chordae tendineae Papillary muscles,Mitral Regurgitation (Insufficiency),Rheumatic disease Endocarditis Mitral valve prolapse Mitral annular enlargement Ischemia Myocardial infarction Trauma Fenfluramine diet suppressants,Prolapsed Mitral Valve Leaflet,Mitral Regurgitation,Pathophysiology of Mitral Regurgitation,Backward flow of blood from LV to LA (Systolic),Increased LA volume and pressure,Increased LV filling (Increased LVEDV),Increased SV,Blood ejected into aorta,Left atrial enlargement,Increased pulmonary venous pressures,Pulmonary edema,Pathophysiology,LV “unloads” itself into left atrium Chronic left atrial overload Chronic overload on left ventricle Volume of regurgitant flow determined by: Ventriculo-atrial gradient Diastolic time Size of the regurgitant orifice Measurements of LV function tend to be slightly elevated Moderately depressed ejection fraction in a patient with MR may be indicative of a severely depressed inotropic state,Natural History,Chronic MR (variable course) Chronic MR may be protected from pulmonary congestion by dilated, highly compliant left atrium Acute MR usually with fulminant pulmonary edema,Mitral Regurgitation,MITRAL REGURGITATION: HEMODYNAMIC GOALS,Hypertrophic Cardiomyopathy,Hypertrophic Cardiomyopathy,Primary disease of cardiac muscle Histologic evidence of myocardial cellular disarray Characteristics LVH (often marked in the septum) Reduced diastolic compliance Subvalvular pressure gradient Ventricular a

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

評(píng)論

0/150

提交評(píng)論